A heart-rate-reducing medication reduces the risk of heart failure and cardiac fibrosis
The findings of a Montreal Heart Institute (MHI) study published in the scientific journal Cardiology suggest that ivabradine, a heart rate reduction medication, is also effective in reducing the risk of diastolic heart failure ...
Jul 28, 2011
0
0